This page will host Events plug-in for all Clarion and trade events.

Upcoming Events

Astria Therapeutics to Present at Upcoming Cantor Global Healthcare Conference

Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will participate in a fireside chat at the upcoming Cantor Global Healthcare Conference on Thursday, September 4 at 3:20pm ET.

A webcast of the presentation can be accessed at the following link: https://sqps.onstreamsecure.com/origin/enliven/players/EnlivenPlayer.html?customerId=22&eventId=98838667&checkCompany=1&checkEmail=1&checkName=1. An archived replay of the presentation will be available in the investors section of www.astriatx.com for 30 days following the event.

About Astria Therapeutics:

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by allergic and immunologic diseases. Our lead program, navenibart (STAR-0215), is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema. Our second program, STAR-0310, is an investigational monoclonal antibody OX40 antagonist in clinical development for the treatment of atopic dermatitis. Learn more about our company on our website, www.astriatx.com, or follow us on Instagram @AstriaTx and on Facebook and LinkedIn.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.35
+2.40 (1.10%)
AAPL  259.26
+0.81 (0.31%)
AMD  233.49
+3.26 (1.41%)
BAC  51.44
+0.34 (0.67%)
GOOG  255.16
+2.63 (1.04%)
META  739.46
+6.05 (0.82%)
MSFT  522.75
+2.22 (0.43%)
NVDA  182.16
+1.88 (1.05%)
ORCL  279.69
+7.03 (2.58%)
TSLA  428.21
-10.76 (-2.45%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.